HomeVTRS • NASDAQ
Viatris Inc
$11.94
After Hours:
$11.94
(0.00%)0.00
Closed: Mar 28, 4:30:00 PM GMT-4 · USD · NASDAQ · Disclaimer
StockUS listed securityUS headquartered
Previous close
$11.83
Day range
$11.78 - $12.02
Year range
$8.74 - $13.62
Market cap
14.18B USD
Avg Volume
11.09M
P/E ratio
263.46
Dividend yield
4.02%
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD)Dec 2023Y/Y change
Revenue
3.84B-1.00%
Operating expense
1.16B5.67%
Net income
-765.60M-175.71%
Net profit margin
-19.95-176.47%
Earnings per share
0.62-7.67%
EBITDA
1.11B-6.91%
Effective tax rate
10.46%
Total assets
Total liabilities
(USD)Dec 2023Y/Y change
Cash and short-term investments
1.18B-19.57%
Total assets
47.69B-4.67%
Total liabilities
27.22B-5.98%
Total equity
20.47B
Shares outstanding
1.19B
Price to book
0.69
Return on assets
2.72%
Return on capital
3.35%
Net change in cash
(USD)Dec 2023Y/Y change
Net income
-765.60M-175.71%
Cash from operations
479.40M236.19%
Cash from investing
115.80M-93.51%
Cash from financing
-926.10M30.40%
Net change in cash
-318.20M-151.98%
Free cash flow
-1.26B-177.93%
About
Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020. The name of the corporation comes from the Latin words via, meaning path, and tris, which means three, referring to the path to three main objectives the corporation set: expanding access to medicines, meeting patient needs through innovation, and earning the trust of the healthcare community. Viatris ranked 254th on the 2021 Fortune 500 rankings of the largest United States corporations based on its 2020 total revenue. Wikipedia
Founded
Nov 16, 2020
Employees
38,000
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu